Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 5, 2006, Pages 1267-1271

  Fayolle, Martine ^a   Ionita, Marina ^a   Krishna, Sanjeev ^b   Morin, Christophe ^a   Patel, Asha Parbhu ^b  

^a UNIVERSITÉ JOSEPH FOURIER   (France)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Carbohydrate transporters; Glucose; Inhibitors; Malaria; PfHT

Indexed keywords

ALKENYL GROUP; ALKYL GROUP; AROMATIC COMPOUND; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; HEXOSE; PERFLUORO COMPOUND;

ARTICLE; BINDING AFFINITY; DRUG STRUCTURE; GLUCOSE TRANSPORT; HETEROLOGOUS EXPRESSION; HEXOSE TRANSPORT; HYDROGEN BOND; LIPOPHILICITY; NONHUMAN; OOCYTE; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; XENOPUS LAEVIS;

MAMMALIA; PLASMODIUM FALCIPARUM; XENOPUS LAEVIS;

EID: 31344457513     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.11.068     Document Type: Article

References (36)

1. For reviews, see inter alia: R.G. Ridley Nature 415 2002 686
2. J. Wiesner, R. Ortmann, H. Jomaa, and M. Schlitzer Angew. Chem., Int. Ed. Engl. 42 2003 5274
3. M.-L. Go Med. Res. Rev. 23 2003 456
4. L. Delhaes, F. Benoit-Vical, D. Camus, M. Capron, and B. Meunier Drugs 6 2003 674
5. N.C. Waters, S.G. Dow, and M.P. Kozar Expert Opin. Ther. Pat. 14 2004 1125
6. H. Staines, J.C. Ellory, and K. Chibale Comb. Chem. High Throughput Screening 8 2005 81
7. T. Joët, C. Morin, J. Fischbarg, A.I. Louw, U. Eckstein- Ludwig, C. Woodrow, and S. Krishna Expert Opin. Ther. Targets 7 2003 593
8. C.J. Woodrow, J.I. Penny, and S. Krishna J. Biol. Chem. 274 1999 7272
9. C.J. Woodrow, R.J.S. Burchmore, and S. Krishna Proc. Natl. Acad. Sci. U.S.A. 97 2000 9931
10. T. Joët, U. Eckstein-Ludwig, and C. Morin Proc. Natl. Acad. Sci. U.S.A. 100 2003 7476
11. For the preparation of O-3 alkyl glucose, see, for example: T. Ikegawa, K. Irinoda, K. Saze, T. Katori, H. Matsuda, M. Ohkawa, and M. Kosik Chem. Pharm. Bull. 35 1987 2894
12. G.E. Fryxell, P.C. Rieke, L.L. Wood, M.H. Engelhard, R.E. Williford, G.L. Graff, A.A. Campbel, R.J. Wiacek, L. Lee, and A. Halverson Langmuir 12 1996 5064
13. M.J. Kates, and J.H. Schaube J. Org. Chem. 61 1996 4164
14. A.N. Singh, V.V. Mhaskar, and S. Dev Tetrahedron 34 1978 595
15. For another synthesis, see: G.B.V. Subramanian, and S. Ahua Indian J. Chem. 35B 1996 724
16. α,ω-Dibromoalkanes with phenyllithium: T.A. Spencer, T.J. Onafrey, R.O. Cann, J.S. Russel, L.E. Lee, D.E. Blanchard, A. Castro, P. Gu, G. Jiang, and I. Shechter J. Org. Chem. 64 1999 807
17. α,ω-Dibromoalkanes with p-butylphenylmagnesium bromide: J. Nishimura, N. Yamada, Y. Horiuchi, E. Ueda, A. Onbayashi, and A. Oku Bull. Chem. Soc. Jpn. 59 1986 2035
18. For a review about antimalarials based on ferrocene, see: C. Biot Curr. Med. Chem. 3 2004 1
19. C.J. Yu, H. Wang, Y. Wang, H. Yowanto, J.C. Kim, L.H. Donilon, C. Tao, M. Strong, and Y. Chong J. Org. Chem. 66 2001 2937
20. The intermediate tosylate is a known compound: A. Toepfer, G. Ktretzchmar, S. Schuth, and M. Sonnetag Bioorg. Med. Chem. Lett. 7 1997 1317
21. G. Bignan, C. Morin, and M. Vidal Carbohydr. Res. 248 1993 371
22. β-Iodo-ethers are reluctant to displacement reactions (see Ref. 16 and refs. therein) and this peculiar stability has resulted in their use for radio-labelling; see: S. Hamant, J.-P. Mathieu, C. Morin, I. Trimcev, and M. Vidal Bioorg. Med. Chem. Lett. 4 1994 1687
23. D.D. Rossouw, and H.H. Coenen Nucl. Med. Biol. 30 2003 373
24. G.H. Lee, E.B. Choi, E. Lee, and C.S. Pak J. Org. Chem. 59 1996 1428
25. For recent reviews: J.C. Biffinger, H.W. Kim, and S. DiMagno ChemBioChem 5 2004 622
26. H.-J. Böhm, D. Banner, M. Kansy, B. Kuhn, K. Müller, U. Stahl, and M. Obst-sander ChemBioChem 5 2004 637
27. W.-Y. Huang, and H.-Z. Zhang J. Fluorine Chem. 50 1990 133
28. M. Lumbierres, M. Moreno-Manas, and A. Valltibera Tetrahedron 58 2002 4061
29. B. Yu, B. Li, J. Zhang, and Y. Hui Tetrahedron Lett. 39 1998 4871
30. Compound 34 was obtained by alkylation of 2 with N-benzyloxy-carbonyl-3- bromopropylamine (prepared according to M.J. Robarge, S.M. Husbands, A. Kyieltyka, R. Brodbeck, A. Thurkauf, and A.H. Newman J. Med. Chem. 44 2001 3175 ) and reduction
31. For another preparation, see: W.M. Corbett J. Chem. Soc. 1961 2926
32. J. Afzal, B.-M. Fung, and E.A. O'Real J. Fluorine Chem. 34 1987 385
33. A.K. Chatterjee, T.-L. Choi, D.P. Sanders, and R.H. Grubbs J. Am. Chem. Soc. 125 2003 11360
34. 12CH-R, due to the presence of differing carbon isotopes, the symmetry is disrupted, which allows the observation of coupling constants. We thank J. Garcia for theoretical simulation of the spectra of E and Z isomers.
35. The presence of ethylenedioxy fragments is known to increase aqueous solubility.
36. Of interest are the recent results (Y. Liu, V.K.- W. Wong, B.C.-B. Ko, M.-K. Wong, and C.-M. Che Org. Lett. 7 2005 1561 ) obtained with artemisinin derivatives in which introduction of lipophilic chains resulted in an up to 200-fold increase in activities